Company News, Regulations

FDA Warns Firms Illegally Selling OTC CBD Topicals for Pain Relief

Products listing CBD as inactive ingredient cited for unapproved drug and misbranding violations.

Author Image

By: Christine Esposito

Editor-in-Chief

The US Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, the warning letters address the illegal marketing of unapproved drugs labeled as containing CBD. The FDA has not approved any over-the-counter (OTC) drugs containing CBD, and none of these products meet the requirements to be legally marketed without an approved new...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters